YU81701A - Cinamoilaminoalkil-supstituisani derivati benzensulfonamida - Google Patents

Cinamoilaminoalkil-supstituisani derivati benzensulfonamida

Info

Publication number
YU81701A
YU81701A YU81701A YUP81701A YU81701A YU 81701 A YU81701 A YU 81701A YU 81701 A YU81701 A YU 81701A YU P81701 A YUP81701 A YU P81701A YU 81701 A YU81701 A YU 81701A
Authority
YU
Yugoslavia
Prior art keywords
compounds
formula
cardiac
cinnamoylaminoalkyl
benzenesulfonamide derivatives
Prior art date
Application number
YU81701A
Other languages
English (en)
Inventor
Holger Heitsch
Heinrich Christian Englert
Klaus Wirth
Heinz Gogelein
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of YU81701A publication Critical patent/YU81701A/sh
Publication of RS50172B publication Critical patent/RS50172B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Dati pronalazak se odnosi na cinamoilaminoalkil-supstituisane derivate benzensulfonamida formule (I) gde A(1), A(2), A(3), R(1), R(2), R(3), R(4), X, Y i Z imaju značenja koja su naznačena u patentnim zahtevima. Jedinjenja formule (I) su korisna farmaceutski aktivna jedinjenja koja pokazuju, na primer, inhibitornu aktivnost na ATP-senzitivne kalijomove kanale u srčanom mišiću i/ili u kardijačnom nervu i pogodna su, na primer, za tretiranje poremećaja kardiovaskularnog sistema kao što su koronarna bolest srca, aritmije, kardijačna insuficijencija ili kardiomiopatije, ili za prevenciju iznenadne kardijačne smrti ili za poboljšanje smanjene kontraktilnosti srca. Pronalazak se dalje odnosi na postupke pripremanja jedinjenja formule (I), njihovu upotrebu i farmaceutske preparate koji sadrže ta jedinjenja.
YUP-817/01A 1999-05-20 2000-05-06 Cinamoilaminoalkil-supstituisani derivati benzensulfonamida RS50172B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19923086A DE19923086A1 (de) 1999-05-20 1999-05-20 Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Publications (2)

Publication Number Publication Date
YU81701A true YU81701A (sh) 2004-07-15
RS50172B RS50172B (sr) 2009-05-06

Family

ID=7908577

Country Status (30)

Country Link
US (1) US6350778B1 (sh)
EP (1) EP1183236B1 (sh)
JP (1) JP4559640B2 (sh)
KR (1) KR100968729B1 (sh)
CN (1) CN1243730C (sh)
AR (1) AR035625A1 (sh)
AT (1) ATE252554T1 (sh)
AU (1) AU771675B2 (sh)
BR (1) BR0010821B1 (sh)
CA (1) CA2374226C (sh)
CZ (1) CZ302943B6 (sh)
DE (2) DE19923086A1 (sh)
DK (1) DK1183236T3 (sh)
EE (1) EE04611B1 (sh)
ES (1) ES2208342T3 (sh)
HK (1) HK1047574B (sh)
HR (1) HRP20010845B1 (sh)
HU (1) HU229041B1 (sh)
IL (2) IL146372A0 (sh)
ME (1) MEP41508A (sh)
MX (1) MXPA01011725A (sh)
NO (1) NO321558B1 (sh)
PL (1) PL201560B1 (sh)
PT (1) PT1183236E (sh)
RS (1) RS50172B (sh)
RU (1) RU2242462C2 (sh)
SK (1) SK287237B6 (sh)
TR (1) TR200103312T2 (sh)
WO (1) WO2000071513A1 (sh)
ZA (1) ZA200109481B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054482A1 (de) * 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN1237185C (zh) * 2003-06-04 2006-01-18 中国科学院上海药物研究所 Sars冠状病毒3cl蛋白酶三维结构模型与抗sars药物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1518816C3 (de) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE1545810A1 (de) * 1965-05-06 1969-12-11 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
DK0612724T3 (da) * 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE4341655A1 (de) 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
JPH0826995A (ja) * 1994-07-22 1996-01-30 Nisshin Flour Milling Co Ltd ベンズイミダゾール誘導体を含有する抗不整脈剤
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
IL141414A0 (en) 1998-09-10 2002-03-10 Aventis Pharma Gmbh Use of benzenesulfonyl (thio) ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl (thio) ureas in combination with beta-receptor blockers
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors

Also Published As

Publication number Publication date
CZ302943B6 (cs) 2012-01-25
TR200103312T2 (tr) 2002-04-22
BR0010821B1 (pt) 2011-07-12
RS50172B (sr) 2009-05-06
NO321558B1 (no) 2006-05-29
AR035625A1 (es) 2004-06-23
SK16692001A3 (sk) 2002-04-04
KR20020005046A (ko) 2002-01-16
CZ20014149A3 (cs) 2002-03-13
PL351751A1 (en) 2003-06-16
ZA200109481B (en) 2002-06-25
BR0010821A (pt) 2002-03-05
WO2000071513A1 (en) 2000-11-30
CA2374226A1 (en) 2000-11-30
ATE252554T1 (de) 2003-11-15
HRP20010845A2 (en) 2003-04-30
IL146372A0 (en) 2002-07-25
HUP0201906A2 (en) 2002-09-28
PT1183236E (pt) 2004-03-31
JP4559640B2 (ja) 2010-10-13
HRP20010845A9 (en) 2010-06-30
HK1047574A1 (en) 2003-02-28
CN1360571A (zh) 2002-07-24
AU5393300A (en) 2000-12-12
RU2242462C2 (ru) 2004-12-20
MEP41508A (en) 2011-02-10
EP1183236B1 (en) 2003-10-22
HK1047574B (zh) 2006-08-04
AU771675B2 (en) 2004-04-01
EE04611B1 (et) 2006-04-17
IL146372A (en) 2007-05-15
SK287237B6 (sk) 2010-04-07
DK1183236T3 (da) 2004-02-23
DE60006104D1 (de) 2003-11-27
EE200100609A (et) 2003-02-17
JP2003500388A (ja) 2003-01-07
EP1183236A1 (en) 2002-03-06
NO20015636D0 (no) 2001-11-19
HRP20010845B1 (en) 2010-08-31
NO20015636L (no) 2002-01-15
DE19923086A1 (de) 2000-11-23
US6350778B1 (en) 2002-02-26
DE60006104T2 (de) 2004-08-05
PL201560B1 (pl) 2009-04-30
KR100968729B1 (ko) 2010-07-08
ES2208342T3 (es) 2004-06-16
MXPA01011725A (es) 2002-04-24
HUP0201906A3 (en) 2005-04-28
CA2374226C (en) 2010-08-31
HU229041B1 (hu) 2013-07-29
CN1243730C (zh) 2006-03-01

Similar Documents

Publication Publication Date Title
TNSN05037A1 (fr) Derives heterobiaryliques servant d'inhibiteurs de metalloproteinases de matrice
BR0313294A (pt) Compostos heteroaromáticos substituìdos com acilamino e seu uso como substâncias farmacêuticas
ATE290525T1 (de) Acylaminoalkyl-substituierte benzolsulfonamidderivate
DE68906609D1 (de) Dopamin-vorlaeufer.
RU92016555A (ru) Дифенилметилпиперазиновые производные и лекарственный препарат на их основе
RU2227751C2 (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
BR9911942B1 (pt) "n-arilamidas de ácido sulfonilaminocarboxílico como ativadores da ciclasse de guanilato e composições farmacêuticas contendo as mesmas"
AU2292900A (en) Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
CA2220533A1 (en) 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
YU81701A (sh) Cinamoilaminoalkil-supstituisani derivati benzensulfonamida
AR029229A1 (es) Compuestos de piperazina sustituida, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento
MX2009012644A (es) Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden.
RU2225403C2 (ru) Сульфонамидозамещенные бензопирановые производные, способ их получения и фармацевтическая композиция на их основе
BRPI0515770A (pt) piperidinassulfoniluréias e tiouréias, preparação das mesmas, uso das mesma e composições farmacêuticas compreendendo-as
RU2223264C2 (ru) Сульфонамидзамещенные аннелированные семичленные циклические соединения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
WO2001085709A3 (en) New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
CA2337397A1 (en) 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
IL155658A0 (en) Heteroarylacryloylaminoalkyl substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
EP0207483A3 (en) Benzimidazoles, process for their preparation, medicaments containing them and intermediates
RU2090202C1 (ru) Сбор для лечения хронической ишемической болезни сердца
UA27973C2 (uk) Лікарський засіб для лікування серцевої недостатності
TH4948EX (th) อนุพันธ์ต่าง ๆ ของ 3-(ไฮดรอกซิเมธิล) -ไอโซควิโนลีน, กรรมวิธีสำหรับการเตรียมสารเหล่านั้น และสารผสมทางเภสัชกรรมที่มีสารชนิดเดียวกันนี้อยู่ด้วย
ECSP961652A (es) Derivados de la 4- mercapto-benzoilguanidina